Dilution profile // every instrument, one screen, from SEC filings

Core Scientific, Inc./tx (CORZ)

CIK 1839341 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHS-1/A on file 2024-04-30
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
HIGHwarrants = 56% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW-16% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2022-03-282026-07-23

Latest: 321.3M shares as of Jul 23, 2026 (10-Q). Share count fell from 386.0M to 177.6M between Oct 30, 2023 and Mar 7, 2024, a pattern consistent with a reverse split (roughly 1-for-2); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool · source filing →

Warrants

TrancheWarrantsExercise priceTermNotes
Warrant Tranche196.4M$6.81
Advanced Micro Devices Inc.Warrants30.0M$23.47
Warrant Tranche26.6M$0.01

Tranches exactly as the company dimensioned them in its 10-Q filed Jul 28, 2026. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.

Warrants outstanding: 180.2M underlying shares, as reported Jan 23, 2024 (10-Q).

Reported exercise price: $11.5 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $5.3M as of Sep 30, 2022.

Rough fully diluted estimate: 501.6M = 321.3M O/S + 180.2M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Senior Secured Notes Due 2031$3.30B$3.30Bnot tagged7.75%
Convertible Senior Notes Due 2031$625.0M$625.0M$22.490%~27.8M sh
3.00 Convertible Senior Notes Due 2029$460.0M$460.0M$113%~41.8M sh

If every note above converted at its tagged price: ~69.6M new shares on 321.3M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.

Notes exactly as the company dimensioned them in its 10-Q filed Jul 28, 2026. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding321.3MJul 23, 2026
+ Warrant Tranche1 (if exercised)96.4MJun 30, 2026
+ Advanced Micro Devices Inc.Warrants (if exercised)30.0MJul 27, 2026
+ Warrant Tranche2 (if exercised)6.6MJun 30, 2026
+ Convertible Senior Notes Due 2031 (if fully converted)27.8MDec 5, 2024
+ 3.00 Convertible Senior Notes Due 2029 (if fully converted)41.8MAug 19, 2024
Fully diluted estimate523.9M+63.1% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

S-1Apr 15, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 0 registered.

EXECUTEDJul 28, 2026Unregistered share sale disclosed (8-K item 3.02)8-K
UPDATEApr 8, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEMar 13, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEMar 7, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEMar 7, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEFeb 27, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEFeb 27, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEFeb 5, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEJan 6, 2025Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEDec 6, 2024Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEDec 6, 2024Prospectus update — often a resale registration, not necessarily new capital424B3
EXECUTEDDec 5, 2024Unregistered share sale disclosed (8-K item 3.02)8-K

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full CORZ workspace